M3V MeVis Medical Solutions AG

24.18USD22.00 EUR · XETRA+2.80%Mkt Cap: 44.01M USDP/E: 51.16

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and…

Key Statistics

Company
Market Cap44.01M USD
Enterprise Value40.00M USD
Revenue (TTM)17.02M USD
Gross Profit17.25M USD
Net Income (TTM)3.48M USD
Revenue/Share9.35 USD
Last Price24.18 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees127
CountryDE
SectorHealthcare
IndustryHealth Information Services
ISINDE000A0LBFE4
Valuation
P/E (Trailing)51.16
P/E (Forward)—
PEG1.36
EV/EBITDA45.40
EV/Revenue2.35
P/S2.59
P/B2.25
EPS (TTM)0.47 USD
EPS (Forward)—
52W Range
20.9938% of range29.46
52W High29.46 USD
52W Low20.99 USD
Profitability
Gross Margin97.70%
Oper. Margin4.18%
EBITDA Margin5.18%
Profit Margin19.71%
ROE17.76%
ROA12.23%
ROIC—
ROCE11.61%
Growth
Revenue Growth-6.80%
Earnings Growth-74.10%
Cash Flow & Leverage
Operating CF4.26M USD
CapEx (TTM)154.37K USD
FCF Margin—
FCF Yield—
Net Debt-4.01M USD
Net Debt/EBITDA-4.55
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio3.16
Quick Ratio3.03
Book Value/Sh10.77 USD
Cash/Share2.20 USD
Dividends
Fwd Div Rate1.04 USD
Trail. Div Rate1.24 USD
Div. Yield4.52%
5Y Avg Yield2.49%
Payout Ratio226.78%
Ex-Div DateMar 20, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.82M
Float479.39K
Insiders73.66%
Institutions23.29%
Technical
SMA 5023.76 (+1.8%)
SMA 20025.58 (-5.5%)
Beta-0.01
S&P 52W Chg8.68%
Avg Vol (30d)231
Avg Vol (10d)311
Technical Indicators
RSI (14)66.4
MACD-0.0967
MACD Signal-0.4055
MACD Hist.+0.3088
BB Upper23.61 USD
BB Middle22.25 USD
BB Lower20.90 USD
BB Width12.20%
ATR (14)0.4270 USD
Vol Ratio (20d)0.95x

About MeVis Medical Solutions (ETR: M3V)

›

MeVis Medical Solutions (ETR: M3V) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 127 employees.

The shares were at 22.00 EUR on 20 November 2026, down 8.0% over 52 weeks. Its 52-week range is 19.10 EUR to 26.80 EUR: the price is 17.9% below the high and 15.2% above the low.

At a market capitalisation of 40.04M EUR, it trades at 51.2 times trailing earnings. The median trailing P/E of its 15 largest Health Information Services peers is 39.9, a premium of 28% for M3V. It pays a dividend yielding 4.52% (it pays out 227% of its earnings), against a median of 0.53% among the dividend payers in that peer group.

MeVis Medical Solutions reports return on equity of 17.8%, an operating margin of 4.2% and revenue down 6.8% year over year.

It holds more cash than debt, a net cash position of 3.65M EUR. Its Piotroski F-score is 6 out of 9, an average reading of its financial health.